BackAlbany Molecular Research Overview

Albany Molecular Research Total Assets

Albany Molecular Research's total assets is $1.2B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.24B
↑ 54.04% YoYΔ $435.87M vs prior year quarter

Peer trimmed avg / median

Loading

Albany Molecular Research Total Assets History

Loading

Albany Molecular Research vs. peers: Total Assets Comparison

Loading

Albany Molecular Research Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Albany Molecular Research (AMRI) FAQ

Albany Molecular Research (AMRI) currently reports a total assets of $1.2B as of June 2017. That compares with $810M in the prior-year period — up 54.0% year over year. Use the charts on this page to explore Albany Molecular Research's total assets history and peer comparisons.

Albany Molecular Research's total assets increased from $810M to $1.2B — a 54.0% year-over-year increase (period ending June 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Albany Molecular Research reported $1.2B in total assets as of June 2017. That compares with $810M in the prior-year period — up 54.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $1.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Albany Molecular Research, and consider following AMRI for alerts when major investors trade the stock.